Tenet Healthcare (NYSE:THC) Director Sells $934,079.28 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Christopher Lynch sold 3,837 shares of the company’s stock in a transaction on Monday, July 27th. The shares were sold at an average price of $243.44, for a total transaction of $934,079.28. Following the completion of the transaction, the director owned 9,568 shares of the company’s stock, valued at $2,329,233.92. This represents a 28.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Tenet Healthcare Stock Down 1.9%

Tenet Healthcare stock opened at $252.80 on Friday. The company has a market capitalization of $21.78 billion, a P/E ratio of 9.75, a PEG ratio of 0.98 and a beta of 1.27. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare Corporation has a fifty-two week low of $156.71 and a fifty-two week high of $262.68. The stock has a 50-day simple moving average of $190.49 and a 200-day simple moving average of $198.96.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. During the same quarter in the previous year, the company posted $4.02 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities research analysts expect that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have commented on THC. Truist Financial lifted their price objective on shares of Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research note on Tuesday. Wells Fargo & Company raised their price target on Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Raymond James Financial set a $270.00 price objective on Tenet Healthcare in a research note on Monday. Morgan Stanley increased their price objective on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, UBS Group boosted their target price on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $268.50.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD grew its holdings in shares of Tenet Healthcare by 1.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after acquiring an additional 119,809 shares during the period. Boston Partners boosted its position in Tenet Healthcare by 15.7% during the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock worth $723,804,000 after purchasing an additional 494,581 shares in the last quarter. AQR Capital Management LLC grew its holdings in Tenet Healthcare by 20.3% in the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock valued at $448,419,000 after purchasing an additional 380,116 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after buying an additional 157,109 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Tenet Healthcare during the 4th quarter worth $248,494,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Analysts raised their price targets: Truist lifted its target to $290, while Guggenheim increased its target to $283 and Robert W. Baird raised its target to $280. The revisions reflect growing confidence in Tenet’s earnings outlook and imply additional upside from recent trading levels. Truist raises Tenet Healthcare price target Baird analyst comments on Tenet Healthcare Guggenheim analyst comments on Tenet Healthcare
• Positive Sentiment: Growth and momentum remain key attractions: Zacks highlighted Tenet’s above-average financial growth, strong momentum characteristics and potential appeal to growth-focused investors. These reports may support continued retail and quantitative-investor interest in THC. Three reasons growth investors may like Tenet Healthcare Tenet Healthcare momentum analysis
• Positive Sentiment: Fundamental performance supports the bullish case: Tenet’s latest quarterly results exceeded estimates, with EPS of $6.12 versus a $4.26 consensus and revenue of $6.04 billion versus $5.43 billion expected. The company also raised its 2026 outlook, strengthening the investment case behind the recent rally.
• Neutral Sentiment: Investor attention is elevated: Zacks reported increased user interest in Tenet and noted that the stock recently reached a 52-week high. However, the coverage is largely informational and does not represent a new company announcement or change in fundamentals. Zacks analysis of investor attention on Tenet Healthcare
• Negative Sentiment: Insider selling creates a modest overhang: EVP Paola Arbour sold 10,878 shares for approximately $2.65 million, while Director Christopher Lynch sold 3,837 shares worth about $934,000. Both transactions significantly reduced their holdings, although the sales may reflect personal financial planning rather than a negative view of Tenet’s prospects.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.